Stock Scorecard
Stock Summary for NovoCure Ltd (NVCR) - $18.86 as of 3/31/2025 2:10:29 PM EST
Total Score
7 out of 30
Safety Score
32 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for NVCR
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NVCR
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NVCR
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for NVCR
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for NVCR (32 out of 100)
| Stock Price Rating (Max of 10) | 6 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for NVCR
Financial Details for NVCR
Company Overview |
|
|---|---|
| Ticker | NVCR |
| Company Name | NovoCure Ltd |
| Country | USA |
| Description | NovoCure Limited, an oncology company, is engaged in the development, manufacture and marketing of Optune for the treatment of a variety of solid tumors. The company is headquartered in Saint Helier, Jersey. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 12/31/2024 |
| Next Earnings Date | 6/5/2025 |
Stock Price History |
|
| Last Day Price | 18.86 |
| Price 4 Years Ago | 75.08 |
| Last Day Price Updated | 3/31/2025 2:10:29 PM EST |
| Last Day Volume | 640,318 |
| Average Daily Volume | 966,122 |
| 52-Week High | 34.13 |
| 52-Week Low | 11.70 |
| Last Price to 52 Week Low | 61.20% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 64.12 |
| Sector PE | 40.10 |
| 5-Year Average PE | -18.84 |
| Free Cash Flow Ratio | 2.16 |
| Industry Free Cash Flow Ratio | 29.26 |
| Sector Free Cash Flow Ratio | 47.05 |
| Current Ratio Most Recent Quarter | 1.49 |
| Total Cash Per Share | 8.73 |
| Book Value Per Share Most Recent Quarter | 3.32 |
| Price to Book Ratio | 5.63 |
| Industry Price to Book Ratio | 5.12 |
| Sector Price to Book Ratio | 21.92 |
| Price to Sales Ratio Twelve Trailing Months | 3.35 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.27 |
| Sector Price to Sales Ratio Twelve Trailing Months | 27.78 |
| Analyst Buy Ratings | 3 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 109,915,000 |
| Market Capitalization | 2,072,996,900 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -6.00% |
| Annual Earnings Growth | -123.75% |
| Reported EPS 12 Trailing Months | -1.56 |
| Reported EPS Past Year | -1.56 |
| Reported EPS Prior Year | -1.95 |
| Net Income Twelve Trailing Months | -149,784,000 |
| Net Income Past Year | -207,043,000 |
| Net Income Prior Year | -92,534,000 |
| Quarterly Revenue Growth YOY | 20.50% |
| 5-Year Revenue Growth | 15.47% |
| Operating Margin Twelve Trailing Months | -38.70% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 959,898,000 |
| Total Cash Past Year | 910,616,000 |
| Total Cash Prior Year | 969,425,000 |
| Net Cash Position Most Recent Quarter | 305,416,000 |
| Net Cash Position Past Year | 341,794,000 |
| Long Term Debt Past Year | 568,822,000 |
| Long Term Debt Prior Year | 565,509,000 |
| Total Debt Most Recent Quarter | 654,482,000 |
| Equity to Debt Ratio Past Year | 0.39 |
| Equity to Debt Ratio Most Recent Quarter | 0.36 |
| Total Stockholder Equity Past Year | 362,496,000 |
| Total Stockholder Equity Prior Year | 441,170,000 |
| Total Stockholder Equity Most Recent Quarter | 360,781,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -78,210,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.71 |
| Free Cash Flow Past Year | -100,429,000 |
| Free Cash Flow Prior Year | 9,430,000 |
Options |
|
| Put/Call Ratio | 0.80 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.78 |
| MACD Signal | -0.88 |
| 20-Day Bollinger Lower Band | 13.87 |
| 20-Day Bollinger Middle Band | 23.76 |
| 20-Day Bollinger Upper Band | 33.64 |
| Beta | 0.63 |
| RSI | 40.52 |
| 50-Day SMA | 20.22 |
| 150-Day SMA | 40.95 |
| 200-Day SMA | 59.69 |
System |
|
| Modified | 3/28/2025 3:25:53 AM EST |